These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37174067)

  • 41. Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia.
    Stangl-Kremser J; Suarez-Ibarrola R; Andrea D; Korn SM; Pones M; Kramer G; Marhold M; Krainer M; Enikeev DV; Glybochko PV; Tamandl D; Shariat SF; Baltzer P
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):309-315. PubMed ID: 31745255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
    Kim CY; Jeong SY; Chong GO; Son SH; Jung JH; Kim DH; Lee SW; Ahn BC; Lee J
    Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis.
    Jin Y; Ma X; Yang Z; Zhang N
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):697-705. PubMed ID: 36720459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.
    Maurits JSF; Sedelaar JPM; Mulders PFA; Aben KKH; Kiemeney LALM; Vrieling A
    Clin Nutr; 2022 Jan; 41(1):131-143. PubMed ID: 34872047
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Vallius T; Hynninen J; Kemppainen J; Alves V; Auranen K; Matomäki J; Oksa S; Virtanen J; Grénman S; Auranen A; Seppänen M
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1224-1232. PubMed ID: 29476227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
    Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
    Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
    [No Abstract]   [Full Text] [Related]  

  • 48. Prognostic analysis of curatively resected pancreatic cancer using harmonized positron emission tomography radiomic features.
    Watanabe M; Ashida R; Miyakoshi C; Arizono S; Suga T; Kanao S; Kitamura K; Ogawa T; Ishikura R
    Eur J Hybrid Imaging; 2023 Mar; 7(1):5. PubMed ID: 36872413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Total Polyunsaturated Fatty Acid Level in Abdominal Adipose Tissue as an Independent Predictor of Recurrence-Free Survival in Women with Ovarian Cancer.
    Salaun H; Poisson M; Dolly A; Arbion F; Servais S; Dumas JF; Goupille C; Ouldamer L
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Adipopenia at Preoperative PET/CT with Mortality in Stage I Non-Small Cell Lung Cancer.
    Choi H; Park YS; Na KJ; Park S; Park IK; Kang CH; Kim YT; Goo JM; Yoon SH
    Radiology; 2021 Dec; 301(3):645-653. PubMed ID: 34609197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
    Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
    JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of Noncancerous Chest CT Features for Predicting Overall Survival and Noncancer Death in Patients With Stage I Lung Cancer Treated With Stereotactic Body Radiotherapy.
    Tahir I; Marquardt JP; Mercaldo ND; Bourgouin PP; Wrobel MM; Mrah S; Sharp GC; Khandekar MJ; Willers H; Keane FK; Fintelmann FJ
    AJR Am J Roentgenol; 2022 Oct; 219(4):579-589. PubMed ID: 35416054
    [No Abstract]   [Full Text] [Related]  

  • 53. Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria.
    Okunade KS; Adejimi AA; Ohazurike EO; Salako O; Osunwusi B; Adenekan MA; Ugwu AO; Soibi-Harry A; Dawodu O; Okunowo AA; Anorlu RI; Berek JS
    JCO Glob Oncol; 2021 Jan; 7():89-98. PubMed ID: 33449803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
    Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis.
    Tranoulis A; Kwong FLA; Lakhiani A; Georgiou D; Yap J; Balega J
    Eur J Surg Oncol; 2022 Jul; 48(7):1441-1454. PubMed ID: 35260290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy.
    Staley SA; Tucker K; Newton M; Ertel M; Oldan J; Doherty I; West L; Zhang Y; Gehrig PA
    Gynecol Oncol; 2020 Mar; 156(3):695-700. PubMed ID: 31928805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
    Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM; Lou G
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).
    Au-Yeung G; Webb PM; DeFazio A; Fereday S; Bressel M; Mileshkin L
    Gynecol Oncol; 2014 Apr; 133(1):16-22. PubMed ID: 24680586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers.
    Han JJ; Yu M; Houston N; Steinberg SM; Kohn EC
    Gynecol Oncol; 2011 Jan; 120(1):5-10. PubMed ID: 20950846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.